A Drug-drug Interaction Study of DP-R213

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to learn about the effect of raloxifene on how the body absorbs and processes cholecalciferol and how cholecalciferol affects raloxifene when they are taken together.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Alvogen Korea
• Treatments: Cholecalciferol; Raloxifene Hydrochloride

Criteria

Inclusion Criteria:

• Healthy male volunteer, age above 19

• The result of Ideal Body Weight(IBW) is not less than -20%, no more than +20%

• Subject who has the ability to comprehend the study objectives, contents and the property of the study drug before participating in the trial.

Exclusion Criteria:

• Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment in completion of this clinical study

• Treatment history of other drugs within last 10 days